Molecular Testing of EGFR, EGFR Resistance Mutation, ALK and ROS1 Achieved by EBUS-TBNA in Chile

Arch Bronconeumol. 2017 Mar;53(3):172-174. doi: 10.1016/j.arbres.2016.08.013. Epub 2016 Nov 5.

[Article in English, Spanish]

Authors

Sebastián Fernandez-Bussy¹, Gonzalo Labarca², Yumay Pires³, Iván Caviedes⁴, Mauricio Burotto⁵

Affiliations

¹ Unidad de Neumología Intervencionista, Clínica Alemana Universidad del Desarrollo, Santiago, Chile. Electronic address: sfernandezbussy@alemana.cl.
² Facultad de Medicina, Universidad San Sebastián, Concepción, Chile.
³ Servicio de Anatomía Patológica, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
⁴ Servicio de Medicina Respiratoria, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
⁵ Servicio de Oncología, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.

PMID: 27825731
DOI: 10.1016/j.arbres.2016.08.013

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Anaplastic Lymphoma Kinase
Biopsy, Fine-Needle / methods
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / pathology
Chile
Female
Genes, erbB-1 / genetics*
Humans
Lung / pathology
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Male
Middle Aged
Mutation*
Prospective Studies
Protein-Tyrosine Kinases / genetics*
Proto-Oncogene Proteins / genetics*
Receptor Protein-Tyrosine Kinases / genetics*
Tomography, X-Ray Computed
Ultrasonography, Interventional / methods

Substances

Proto-Oncogene Proteins
ALK protein, human
Anaplastic Lymphoma Kinase
Protein-Tyrosine Kinases
ROS1 protein, human
Receptor Protein-Tyrosine Kinases